• Explore /
  • Poster
  • / Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced gastric or gastroesophageal junction cancer from JAVELIN solid tumor phase Ib trial: Analysis of safety and clinical activity.

Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced gastric or gastroesophageal junction cancer from JAVELIN solid tumor phase Ib trial: Analysis of safety and clinical activity.

Abstract Poster

Authors

null

Hyun Cheol Chung

Yonsei Cancer Center, Seoul, Korea, The Republic of

Hyun Cheol Chung , Hendrik-Tobias Arkenau , Lucjan Wyrwicz , Do-Youn Oh , Keun-Wook Lee , Jeffrey R. Infante , Sung Sook Lee , Jeeyun Lee , Ulrich Keilholz , Alain C. Mita , Elizabeth R. Plummer , Margaret Kemeny , Bohuslav Melichar , Denis Michel Smith , Kevin M. Chin , Anja von Heydebreck , Jean-Marie Cuillerot , Yoon-Koo Kang , Howard Safran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01772004

Citation

J Clin Oncol 34, 2016 (suppl; abstr 4009)

DOI

10.1200/JCO.2016.34.15_suppl.4009

Abstract #

4009

Poster Bd #

1

Abstract Disclosures

Similar Posters

First Author: Karen Kelly

First Author: Christophe Le Tourneau

First Author: Hyun Cheol Chung

First Author: Arun Rajan